Operating Expenses 변화 날짜
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
BioCryst Pharmaceuticals USD 98.66M 33.55M 2023-09
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Bluebird Bio USD 97.12M 4.93M 2023-09
Esperion Therapeutics USD 61.5M 1.34M 2023-09
Immunic USD 23.57M 1.45M 2023-09
Insmed USD 261.96M 35.22M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Kyowa Hakko Kirin JPY 69.82B 26.68B 2023-09
Moderna USD 2.8B 1.04B 2023-12
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
PTC Therapeutics USD 438.79M 124.05M 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09
Xoma USD 6.62M 998K 2023-09



Ultragenyx Pharmaceutical 운영 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Mar 2024.